Insulin aspart: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (11 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
<StructureSection load='' size='340' side='right' caption='PDB ID [[4gbc]]' scene='96/968809/Cv/ | <StructureSection load='' size='340' side='right' caption='Human modified insulin complex with cresol Zn+2 and Cl-; PDB ID [[4gbc]]' scene='96/968809/Cv/3'> | ||
Insulin aspart, sold under the brand name NovoLog and Fiasp, among others, is a modified type of medical insulin used to treat type 1 and type 2 diabetes. See also [https://en.wikipedia.org/wiki/Insulin_aspart]. | Insulin aspart, sold under the brand name NovoLog and Fiasp, among others, is a modified type of medical insulin used to treat type 1 and type 2 diabetes. See also [https://en.wikipedia.org/wiki/Insulin_aspart Insulin aspart] and [[Insulin]]. | ||
<scene name='96/968809/Cv/4'>Hexamer of the human insulin variant B28Asp at pH 6.5</scene> (PDB ID [[4gbc]]). | |||
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||
Latest revision as of 10:58, 28 February 2024
Insulin aspart, sold under the brand name NovoLog and Fiasp, among others, is a modified type of medical insulin used to treat type 1 and type 2 diabetes. See also Insulin aspart and Insulin. (PDB ID 4gbc).
|
| ||||||||||